By leveraging the specific binding of TfR and transferrin (Tf), Tf-LPD was targeted to glioma cells, facilitating dual functions of MRI imaging monitoring and targeted therapy for gliomas, thus providing a novel theranostics strategy for glioma management. This evidence concerns the gene TFRC and central nervous system cancer.